The guanine nucleotide exchange factor Vav1 is essential for transducing T cell antigen receptor signals and therefore plays an important role in T cell development and activation. Our previous genetic studies identified a locus on rat chromosome 9 that controls the susceptibility to neuroinflammation and contains a non-synonymous polymorphism in the major candidate gene Vav1. To formally demonstrate the causal implication of this polymorphism, we generated a knock-in mouse bearing this polymorphism (Vav1 R63W we show that this lowered cytokine production is intrinsic to effector CD4 T cells and that Treg depletion has no impact on EAE development. Finally, we provide a mechanism for the above phenotype by showing that the Vav1 R63W variant has normal enzymatic activity but reduced adaptor functions. Together, these data highlight the importance of Vav1 adaptor functions in the production of inflammatory cytokines by effector T cells and in the susceptibility to neuroinflammation.
Introduction
The guanine nucleotide exchange factor (GEF) Vav1 is essential for transducing T cell antigen receptor (TCR) signals and therefore plays a critical role in the development and activation of T cells [1] [2] [3] [4] [5] . Following TCR engagement, Vav1 becomes rapidly tyrosine phosphorylated by kinases of the Src and/or Syk family. This phosphorylation relieves Vav1catalytic Dbl homology (DH) domain and causes Vav1 to promote GDP-GTP exchange on the Rho, Rac1 and Cdc42 small GTPases [6, 7] . In addition to this GEF activity, the CH, SH2 and SH3 domains of Vav1 allow its incorporation into the LAT-Grb2-Gads-PLCγ1-SLP76 micro-clusters that form at the immunological synapse. Binding of Vav1 appears to stabilize this molecular complex thereby controlling PLCγ and nuclear factor of activated T cells (NFAT) activation [1, 8, 9] . In Vav1-deficient mice, T cell development is partially blocked at the pre-TCR checkpoint in the thymus and both positive and negative selections of T cells are strongly impaired [3, 5] . Furthermore, TCR-induced activation and proliferation is greatly diminished in Vav1-deficient T cells, due to reduced TCR-induced signaling that impacts on Ca 2+ flux, on the activation of Erk, protein kinase D1 (PKD1) and serine-threonine kinase Akt, and on the activity of transcription factors such as NFAT and nuclear factor κB (NF-κB) [1, 2, 10] . A recent study has shown that many critical events involved in T cell activation are mediated by either the GEF or the scaffolding activities of Vav1 [11] . The GEF activity of Vav1 is necessary for T cell development and for the optimal activation of T cells, including signal transduction to Rac1, Akt, and integrins. In contrast, Vav1 GEF activity is not required for TCR-induced Ca 2+ flux, activation of Erk and PKD1, cell polarization and development of regulatory T cells (Treg). Lewis (LEW) and Brown-Norway (BN) rats behave in opposite ways concerning their susceptibility to autoimmunity, allergy and infectious diseases [12, 13] . Genetic dissection using these rat strains has identified a locus of 117 kb on chromosome 9 that controls natural Treg development [14] . Fine mapping of this locus revealed a non-synonymous SNP in the Vav1 gene leading to the substitution of an arginine residue by a tryptophan at position 63 (R63W) in BN rats. Interestingly, this 117 Kb interval is fully included in the Eae4 locus of 1 cM that controls the susceptibility to central nervous system (CNS) inflammation [15] . Although this study suggested that Vav1 could be involved, one important limitation was the possibility that other genetic variants contained in the 117 Kb fragment besides the Vav1 R63W polymorphism could be responsible for these phenotypes.
Here, we sought to unequivocally test the involvement of the Vav1 R63W polymorphism in the susceptibility to CNS inflammation and to determine its mechanisms of action. To this aim, we generated a knock-in mouse model in which the arginine at position 63 was replaced by a tryptophan residue. Using this model, we show that Vav1 R63W mice display reduced susceptibility to experimental autoimmune encephalomyelitis associated with a lower production of effector cytokines by autoreactive CD4 T cells that is intrinsic to effector CD4 T cells. Finally, we provide a mechanism for the above phenotype by showing that the Vav1 R63W variant has normal enzymatic activity but reduced adaptor functions. Together, these data highlight the importance of Vav1 adaptor functions in the production of inflammatory cytokines by CD4 T cells and in the susceptibility to neuroinflammation.
Results

The Vav1
R63W polymorphism impairs thymic selection
The development of T cells in the thymus proceeds through a series of stages that are controlled by signals triggered by the pre-TCR and TCR complexes. We analyzed the impact of the Vav1 R63W polymorphism on these stages by using Vav1 R63W mice (S1 Fig . We observed that the generation of thymocytes expressing the ovalbumin-specific TCR was impaired in Vav1 R63W mice (Fig 1D) . Similar results were obtained using female HY-TCR transgenic mice whose Vβ6 + TCR recognizes a male-specific antigen presented by MHC class II I-A b ( Fig 1E) . Next, we investigated the effect of the Vav1 R63W mutation on negative selection. As previously reported [16] , male HY-TCR transgenic mice displayed a dramatic reduction of DP cells in the thymus due to early stage negative selection. In contrast, male HY-TCR transgenic mice in a Vav1 R63W background had twice as many thymocytes, resulting from increased DP cells (Fig 1F) . These data indicate that negative selection is also impaired in Vav1 R63W KI mice. Collectively, our results reveal that Vav1 R63W has no major effect on the pre-TCR checkpoint but rather causes a defect in TCRdriven positive and negative selections of DP thymocytes.
The Vav1 R63W polymorphism modifies T cell functions
Although Vav1 R63W mice exhibit a defect in thymic development, there were no significant differences in the proportion and absolute numbers of CD4 and CD8 T cells in lymph nodes (Fig  2A) R63W (n = 4) mice. Graphs show the absolute numbers of total thymocytes and of each indicated population. (E and F) Representative dot plots of CD4 and CD8 expression on thymocytes of female (E) and male (F) HY-TCR transgenic WT (n = 5 for females, n = 13 for males) and Vav1 R63W mice (n = 10 for females, n = 12 for males). Graphs show the absolute numbers of total thymocytes and of each indicated population. The values in dot plots represent the mean percentages of each population ± SEM. For A, C, E and F, the data represents the pool of three independent experiments. ■: Vav1 R63W mice; □: WT mice; *p 0.05; **p 0.01; ***p 0.001. draining lymph nodes (Fig 4A) . Using tetramer staining, we showed similar frequencies of MOG -specific CD4 T cells in the brain (Fig 3D) and draining LNs (Fig 3E) of WT and Vav1 R63W mice, although a moderate decrease was observed in the spinal cord of Vav1 R63W mice ( Fig 3D) . This suggests that the reduced cytokine expression is not the consequence of impaired development or expansion of MOG-specific CD4 T cells. We next examined whether the defect in cytokine production observed in Vav1 R63W mice is intrinsic to effector CD4 T cells or is the consequence of either increased Treg frequency or modified function of other immune cells such as APCs. For this purpose, we generated mixed bone marrow chimeras by transferring a 1:1 mixture of bone marrow from WT mice bearing the congenic CD45.1 marker and Vav1 R63W mice bearing both CD45.1 and CD45.2 congenic markers into irradiated lymphopenic CD45.2 recipient mice. These chimeras revealed that the cytokine profile of Vav1 R63W CD4 T cells upon MOG immunization was not influenced by the presence of hematopoietic cells from WT mice (Fig 4B) . In addition, we showed that reduced EAE course in Vav1 R63W mice was not changed by the depletion of Treg by one single injection at day 17 of the anti-CD25 PC61 mAb which depletes Tregs (Fig 4C) . Altogether, our results highlight the key role of Vav1 in the pathophysiology of EAE and suggest that the Vav1 R63W polymorphism protects against the development of CNS inflammation by reducing the production of encephalitogenic cytokines by autoreactive CD4 T cells.
The Vav1 R63W mutation reduces Vav1 adaptor functions
We next investigated which Vav1-dependent TCR signaling pathways were affected by the Vav1 R63W mutation. We first showed that the Vav1 R63W variant was highly phosphorylated, together with a 75% reduction of its expression at the protein level (Fig 5A) . Vav1 R63W had, however, no impact on proximal TCR signaling, as revealed by normal phosphorylation levels of ZAP70, LAT and Lck (Fig 5B) . In contrast, this variant strongly impaired Vav1-dependent distal TCR signaling, as evidenced by a significant reduction in the phosphorylation of Erk, Akt and p38 ( Fig 5C) . Further, this was associated with reduced calcium flux after TCR engagement ( Fig 5D) . In contrast, the TCR induced activation of Rac1 was normal in Vav1 R63W mice, suggesting normal GEF activity (Fig 5E) . Therefore, the biological effects of the Vav1 
Discussion
In the present study, we analyzed the impact of the recently identified Vav1 R63W variant on the development and functions of T cells, as well as on the susceptibility to CNS neuroinflammation. In contrast to Vav1 deficiency [1, 3, 5] , we found that the Vav1 R63W variant had only mild effects on thymic development of T cells and on T cell homeostasis in the periphery. In addition, the Vav1 R63W KI mice were less susceptible to CNS inflammation, resulting from a reduced production of inflammatory cytokines (IFN-γ, IL-17 and GM-CSF) by autoreactive CD4 T cells. Despite an increased proportion of Foxp3 Treg cells in Vav1 R63W mice, the reduction in cytokine production was intrinsic to effector CD4 T cells and depletion of Treg cells had no impact on EAE development. Finally, we showed that Vav1 R63W had normal GEF activity but reduced adaptor functions. Together, the analysis of this natural Vav1 variant formally established for the first time that Vav1 adaptor functions are essential for both T cell functions and susceptibility to autoimmune neuroinflammation. The interaction between the TCR and MHC-peptide complexes leads to the initiation of TCR signaling and represents a key step for the orchestration of the adaptive immune response. Indeed, the intracellular signaling pathways triggered upon TCR engagement finely control the thymic ontogeny of T cells, the mature T cell differentiation, expansion and activation [18, 19, 20] . In the thymus, engagement of the pre-TCR leads to the differentiation of the most immature DN thymocytes towards the DP stage, through a selection process called β-selection. Next, DP thymocytes expressing a mature TCRαβ and displaying low avidity for self-peptide-MHC complexes undergo a process of positive selection into either MHC class II-restricted CD4 +-
CD8
-or MHC class I-restricted CD4 -CD8 + SP cells. Conversely, DP thymocytes that have a TCR with high avidity for self-peptide-MHC are eliminated by negative selection. The outcome of these different selection events is critically dependent on TCR signaling. Studies of Vav1-deficient mice have shown that the development of T cells is partially blocked at the pre-TCR checkpoint in the thymus, leading to a strongly block of both positive and negative selections [1, 3, 5] . In contrast, our results reveal that Vav1 R63W has no major effect on the pre-TCR is particularly relevant when considering that several studies have established that IFN-γ, IL-17 and GM-CSF are the main effector cytokines in the pathophysiology of both EAE and multiple sclerosis [21] [22] [23] . In addition, our findings are fully in line with our previous study using cohorts of patients with multiple sclerosis, in which we demonstrated a strong association between Vav1 expression, susceptibility to multiple sclerosis and production of inflammatory cytokines by CD4 T cells [15] . Our results, however, contrast with data using Vav1-deficient CD4 T cells or CD4 T cells harboring a mutated Vav1 with defective GEF activity, which rather showed increased production of IFN-γ [11, 24 ] . The signaling pathway that depends on Vav1 adaptor function, therefore, plays an important role in Th1/Th17 differentiation and could be targeted for immunomodulation of immune mediated diseases. The differentiation of naïve CD4 T cells into functionally polarized T helper cell subsets depends notably on the strength of TCR-dependent signaling pathways upon antigen recognition [19] . In general, weak TCR signaling leads to transient Erk activation and favors Th2/Treg differentiation, whereas stronger TCR signaling leads to sustained Erk activation and favors Th1/Th17 differentiation [19, 25, 26] . Our findings are in line with these data, since we showed that Vav1 R63W leads to a reduction of TCR signaling as revealed by a decrease of calcium flux and of Erk, Akt and p38 activities, which was associated with a decreased production of IFN-γ, IL-17 and GM-CSF by CD4 T cells. Of note, it was shown that Erk inhibitors could attenuate EAE by suppressing autoantigen-specific Th17 and Th1 responses [27] . Moreover, the genetic ablation of Erk2 impedes Th1 differentiation, while enhancing the development of induced Treg [28] . Concerning the p38 MAPK pathway, it has been shown that a single copy disruption of the p38 gene or a p38 inhibitor markedly reduce the pathogenesis of EAE by decreasing IL-17 production [29, 30] . In contrast, the role of Akt-dependent pathways and calcium flux in CD4 T cell differentiation remains contradictory [31] [32] [33] [34] [35] The capacity to produce knockout mice has dramatically accelerated our knowledge on the immunological consequences of the complete loss of critical components of the TCR signaling pathways. However, in humans, the largest source of genetic variation is rather composed of single-nucleotide substitutions, for which it is far more difficult to predict their physiological consequences. Importantly, these can often affect biological pathways in unpredictable ways, as revealed recently by the use of mouse models with hypomorphic variants for SLP76, LAT and Zap70 [36] [37] [38] [39] . Our study reveals that the Vav1 R63W model described herein is instrumental to expand our understanding of the immunological consequences of genetic variations of Vav1 expression and function. This model highlights the importance of Vav1 adaptor functions in the differentiation of CD4 T cells into Th1/Th17 subsets and suggest that genetic or acquired alterations in Vav1 signaling could play a major role in susceptibility to the many immunemediated diseases, including autoimmune diseases where Th1/Th17 play a preponderant role.
Materials and Methods
Generation of Vav1 R63W knock-in mice
Vav1 protein is evolutionarily conserved from nematodes to mammals and the analysis of rat and mouse Vav1 sequences revealed 98% homology. Comparative genomics studies indicated that the arginine found at position 63 in LEW rats is highly conserved among species while the tryptophan at this position is peculiar to BN rats. A genomic fragment containing exon 1 of the Vav1 gene was isolated from a BAC clone of C57BL/6 origin. The CGG codon found in exon 1 of the Vav1 gene and coding for the arginine residue present at position 63 of Vav1 was converted into a TGG codon coding for a tryptophane. A loxP-tACE-CRE-PGK-gb2-neor-loxP cassette (NEO; [38] ) was introduced in the intron separating exons 1 and 2 of the Vav1 gene (S1A Fig). After electroporation of JM8.F6 C57BL/6N ES cells [40] and selection with G418, colonies were screened for homologous recombination by Southern blot. The 3' single-copy probe corresponded to a 582 bp genomic fragment located in intron 1 (denoted 3' probe in S1A Fig 
Antibodies for flow cytometry and Elisa
The mAbs used for flow cytometry were as follows: RM4-5 (anti-mouse CD4), 53-6.7 (anti-mouse CD8α), IM7 (anti-mouse CD44), PC61 (anti-mouse CD25), MEL-14 (anti-mouse CD62L), H57-597 (anti-mouse TCR αβ), FJK-165 (anti-mouse Foxp3), 53-7.3 (anti-mouse CD5), A20 (antimouse CD45.1), 104 (anti mouse CD45.2), anti-mouse IL-17A, anti-mouse GM-CSF, anti-mouse IFN-γ. The fluorescent conjugated antibodies were purchased from e-Biosciences, BD Biosciences and Biolegend. Antibodies used for ELISA were: 11B11 (anti-IL-4), AN18 (anti-IFN-γ), purified anti-mouse IL-17A, purified anti-mouse GM-CSF, Biotin anti-mouse IFN-γ (XMG1.2), Biotin anti-mouse IL-17A, Biotin anti-mouse GM-CSF. These antibodies were purchased from BD Biosciences. The BVD6-24G2 (anti-mouse IL-4 Biotin) is from e-Biosciences.
Induction of experimental autoimmune encephalomyelitis (EAE)
The MOG (MEVGWYRSPFSRVVHLYRNGK) peptide was purchased from Polypeptide Laboratories (San Diego, CA) with a purity grade >95%. 8-12 week-old mice were immunized subcutaneously at the base of the tail with 50 μg or 100 μg of MOG peptide emulsified in CFA (BD Difco, Franklin Lakes NJ) containing 500 μg of Mycobacterium tuberculosis (Strain H37, Difco). For active EAE, mice were injected intravenously with 200 ng of pertussis toxin (List Biological Laboratories, Campbell, CA) at days 0 and 2 post-immunization. Clinical scores were recorded daily as follow: 0, no signs of disease; 1, loss of tone in the tail; 2, hind limb paresis; 3, hind limb paralysis; 4, tetraplegia; 5, moribund. Intraperitoneal injection with anti-CD25 mAb (PC61) (500 μg/ml) antibody was performed at day 17 after MOG 35-55 peptide immunization.
Isolation and functional characterization of CNS mononuclear cells
Mice were anesthetized with Ketamine and perfused with cold PBS. Brain and spinal cord were collected separately, homogenized and digested with collagenase D (2.5 mg/ml, Roche Diagnostics), Dnase I (10 μg/ml) and TLCK (1 μg/ml, Roche, Basel, Switzerland) for 30 min at 37°C. Cells were then washed, suspended in 37% Percoll, and layered on 70% Percoll. 
Purification of CD4 T cell subsets and Treg cell suppression assay
To purify naïve CD4 + CD62L + T cells, CD4 T cells were negatively selected using Dynal cocktail antibodies supplemented with PC61 (an anti-CD25 mAb) to eliminate Treg cells. Cells were then positively selected with anti-CD62L beads on MS columns (Miltenyi, Auburn CA) according to the manufacturer's instructions. For functional test, naïve CD4 T cells were stimulated with plate-bound anti-CD3 (3 μg/ml) and soluble anti-CD28 (1 μg/ml). 
Cytokine measurement
Enzyme immunoassays were used to measure cytokines in culture supernatants. 96 well plates were coated for 2 h at 37°C with anti-IFN-γ, anti-IL-17 or anti-GM-CSF in carbonate buffer 0.05 M pH 9.6. Culture supernatants or standards were incubated 2 h at 37°C. The plates were then incubated for 1h30 min with a secondary biotinylated antibody specific for each cytokine, followed by 20 min incubation with streptavidin-phosphatase alkaline at 37°C. Finally, plates were revealed by phosphatase alkaline substrate and absorbance was measured at 450/540 nm. 
Analysis of TCR signaling in CD4 T cells
Purified CD4 T cells were stimulated at 37°C in non-supplemented RPMI 1640 using preformed complexes of biotinylated anti-CD3 (clone 145-2C11, Biolegend, 30 μg/ml /10 7 cells), anti-CD4 (GK1.5, Biolegend, 30 μg/10 7 cells) and streptavidin (15 μg/10 7 cells). Stimulation was stopped by the addition of twice-concentrated lysis buffer (100 mM Tris, pH 7.5, 270 mM NaCl, 1 mM EDTA, 20% glycerol and 0.2% n-dodecyl-β-maltoside) supplemented with protease and phosphatase inhibitors. After 10 min of incubation on ice, cell lysates were centrifuged at 20,000 x g for 15 min at 4°C. The protein concentration was first assessed using bradford assay and normalized. Proteins were then denatured in Laemmli buffer and analyzed by SDS-PAGE followed by Western blotting on PVDF membranes (Immobilon). ECL Prime (Amersham) was used as revelation substrate. Signal intensity quantification was performed using ImageJ software (1.47v). Two loadings were performed simultaneously for each time point, one for phosphoproteins and the other for total proteins. A GAPDH staining was also performed on each blot as loading control. The blots were then scanned, bands of interest were quantified and background line was subtracted. To determine specific phosphorylation, the signal from phosphorylated bands was divided by the appropriate loading control and all values were expressed as a fold increased of bands intensity. Signals below detection were set at 0. The antibodies used for biochemical studies were, anti-Vav1 (C-14) and anti-P-Vav1 Tyr174 From Santa Cruz Biotechnology, anti-LAT (1D-1) from Thermo Scientific, anti-P-LAT (pY226) from BD Pharmingen, anti-Akt, anti-P-Akt Ser473 (D9E), anti-P-Erk1/2 Thr202/Tyr204 (D13.14.4E), anti-Erk (3A7), anti ZAP-70 (D1C10E), anti-P-ZAP70 (Tyr319), HRP-linked anti-rabbit IgG, HRP-linked anti-mouse IgG, and HRP-linked anti-rabbit IgG from Cell Signaling Technologies. Rac1 pull-down assays were performed using Rac1 activation Assay Biochem Kit (Cytoskeleton) following the manufacturer's instructions.
Calcium flux analysis
For Calcium flux analysis, CD4 T cells were loaded at 37°C for 30 min with the fluorescent calcium indicator Indo-1 (Invitrogen) at 5 μM. The cells were then washed and stained with surface markers (TCR and CD4). Ca influx was measured by flow cytometry using an LSRII (BD Bioscience). Cells were incubated with 0.5 μg/ml of biotylinated anti-CD3 mAb (145-2C11) at 37°C for 30 sec. Medium were then added and baseline level was measured for 30s, at which time streptavidin (Sigma-Aldrich) was added at 1 mg/ml as a cross-linker. Finally ionomycin was added at 2 μg/ml to all samples to verify Indo-1 labeling. The relative concentration of Ca was measured as the ratio between the Ca-bound dye and the Ca free dye. Data were analyzed using FlowJo software.
Data analysis
Data are expressed as mean ± s.e.m. The GraphPad Instat statistical package was used for statistical analyses (GraphPad Software, Inc., La Jolla, CA USA). Results were compared using Mann-Whitney test. Results were considered statistically significant when the p value was <0.05.
Ã : p<0.05; ÃÃ : p<0.01; ÃÃÃ : p<0.001.
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